NovoPedics’ MeniscoFix Granted Breakthrough Device Designation

FDA has granted NovoPedics a Breakthrough Device Designation, which will expedite development and prioritize review of the MeniscoFix™ device.

Further, the U.S. Department of Defense awarded a $4.42 million grant to research and development teams at Rutgers University and NovoPedics to support further pre-clinical development of MeniscoFix.
...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0